Study finds semaglutide provides benefits for patients with obesity phenotype of heart failure and HFpEF

Researchers evaluated the efficacy of semaglutide in patients with the obesity phenotype of heart failure and preserved ejection fraction.

Living past 100: Healthy habits, good company, and a purpose in life

Researchers explore the secrets behind increased life expectancies, focusing on the influence of diet, lifestyle, and socio-economic changes. Centenarians, individuals living past 100, often delay

October 11, 2023

More Beans, Less Red Meat: Nutritionists Weigh in on U.S. Dietary Guidelines

Americans should eat more beans, peas, and lentils and cut back on red and processed meats and starchy vegetables, all while continuing to limit added

December 11, 2024

Clearmind Medicine Closes US$2.25 Million Public Offering – Psychedelic Alpha

Tel Aviv, Israel / Vancouver, Canada, Sept. 18, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind”), a biotech company

September 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.